Romanian Journal of NEUROLOGY Logo
  • Home
  • Aims & Scope
  • Standards
    • Instructions for authors
    • Peer-review protocol
    • Open Access
  • EDITORIAL COUNCIL
  • Peer-Review Council
  • EMC | CME
  • How to
  • SUBSCRIBE
  • Menu

Author archives

  • About
  • Latest Posts

Lacramioara Perju-Dumbrava

Latest posts by Lacramioara Perju-Dumbrava (see all)

  • NEW INSIGHTS IN THE NATURAL HISTORY OF EARLY-ONSET MULTIPLE SCLEROSIS - 31/10/2016
  • RASMUNSSEN ENCEPHALITIS IN YOUNG ADULT: A CASE REPORT - 26/04/2016
  • VISUAL DISTURBANCES IN PARKINSON’S DISEASE PATIENTS - 20/01/2016

Articles signed on Romanian Journal of NEUROLOGY:

NEW INSIGHTS IN THE NATURAL HISTORY OF EARLY-ONSET MULTIPLE SCLEROSIS

SELECT ISSUE

Romanian Journal of Neurology, Volume XV, No. 3, 2016
ISSN 1843-8148  |  e-ISSN 2069-6094
ISSN-L 1843-8148
DOI: 10.37897/RJN

Indexată BDI  |  IDB Indexed

DOAJ
Ebsco Host - Medline
Scopus
DOI - Crossref

HIGHLIGHTS

Plagiatul – în actualitate

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

NEW INSIGHTS IN THE NATURAL HISTORY OF EARLY-ONSET MULTIPLE SCLEROSIS

Romana Homorodean and Lacramioara Perju-Dumbrava

 ABSTRACT

Background. The early onset forms of Multiple Sclerosis (Paediatric MS, P-MS) have a low frequency, occurring in 2% to 10% of all MS cases. Age at diagnosis is a key feature for disease progression and prognosis in MS patients.
Objective. To evaluate the clinical features and course of MS in patients having the disease onset before the age of 18, according to age at diagnosis.
Methods. Patients with MS onset before age of 18 identified from Basse-Normandie MS regional registry, were included in the study. Patients were divided in two groups according to the age at MS diagnosis: the first group (group A) of patients in whom MS diagnosis was set before age of 18 and the second group (group B) including patients older than 18 years at MS diagnosis. Data related to clinical features and disease course were evaluated and compared between the two groups and also with some clinical data of adult MS patients included in the same regional database.
Results. A total of 41 patients with P-MS were included in the study, represented by 20 patients in group A and 21 patients in group B. Patients from group A had a more rapid progression to mild handicap (EDSS 3.0) than patients from group B (time to reach EDSS 3.0 of 6.34 vs 14.36 years; p=0.02) and they reached this level of disability at a younger age (21.17 vs 29.79 years; p=0.002). The duration of the first remission was significantly shorter in group A (1.44 vs 5.14 years; p<0.001) and the evolution to secondary-progressive (SP) form was faster when compared to group B (14.97 vs 27.57 years; p=0.01). Patients from group A had a greater risk to reach EDSS 3.0 or EDSS 6.0 as well as a greater probability to reach SP form (p<0.001) than patients from group B. Progression index (PI) of the entire paediatric group was significantly lower than mean PI in the adult group (0.29 vs 0.45; p=0.003) but not significantly different between the two groups (0.37 in group A vs 0.21 in group B).
Conclusion. P-MS forms show some clinical peculiarities, especially those with the age of diagnosis less than 18 years. They seem to have a more severe clinical MS course and a faster progression of disability.

Keywords: paediatric multiple sclerosis, epidemiology, course

Full text | PDF

RASMUNSSEN ENCEPHALITIS IN YOUNG ADULT: A CASE REPORT

SELECT ISSUE

Romanian Journal of Neurology, Volume XV, No. 1, 2016
ISSN 1843-8148  |  e-ISSN 2069-6094
ISSN-L 1843-8148
DOI: 10.37897/RJN

Indexată BDI  |  IDB Indexed

DOAJ
Ebsco Host - Medline
Scopus
DOI - Crossref

HIGHLIGHTS

Plagiatul – în actualitate

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

RASMUNSSEN ENCEPHALITIS IN YOUNG ADULT: A CASE REPORT

Nicoleta Tohanean, Oana Vanta, Alexandru Centea, Teodora Alexescu and Lacramioara Perju-Dumbrava

ABSTRACT

Rasmunssen encephalitis is a rare disease characterized by focal cortical inflammation with progressive extension and diffusion. Clinical features are continuous partial epilepsy non responsive to usual anti-epileptic therapy and unilateral motor deficit, corresponding with the IRM imaging to cerebral hemiatrophy. The disease mainly affects children but there are some acknowledged cases described in adolescent and adult life. 
This report aims to present a clinical case of a young female with seven years personal history of generalized epilepsy. Having a clinical and paraclinical evolution a suspicion of chronic focal Rasmunssen encephalitis took shape. During admission she suffered of weakness and involuntary movements in her left side, which gradually worsened in the last month and memory impairment also. Routine laboratory blood evaluation, inflammatory and infectious tests were within the normal range. Magnetic resonance imaging of the brain reveals T2 atrophy of the right cerebral hemisphere with a low displacement of median structures to the left and an abnormal hyper intensity signal on T2-weighted, along with FLAIR images. Electroencephalography showed a profoundly altered, slowed, asymmetrically with paroxysmal unilateral right slow activity record with high amplitude. Based on clinical criteria, MRI imaging and EEG we supported the diagnosis of Rassmunsen encephalitis.

Keywords: Rasmunssen, continuous partial epilepsy, antibodies anti-GluR3

Full text | PDF

VISUAL DISTURBANCES IN PARKINSON’S DISEASE PATIENTS

SELECT ISSUE

Romanian Journal of Neurology, Volume XIV, No. 4, 2015
ISSN 1843-8148  |  e-ISSN 2069-6094
ISSN-L 1843-8148
DOI: 10.37897/RJN

Indexată BDI  |  IDB Indexed

DOAJ
Ebsco Host - Medline
Scopus
DOI - Crossref

HIGHLIGHTS

Plagiatul – în actualitate

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

VISUAL DISTURBANCES IN PARKINSON’S DISEASE PATIENTS

Nicoleta Tohanean, Lucia Muntean, Horea Demea and Lacramioara Perju-Dumbrava

ABSTRACT

Stroke represents the main cause of disability in adults. The disability is caused by motor or sensitive impairment, loss of interjoint coordination, spasticity and pathological synergies that occur after stroke. The new directions in motor rehabilitation point at facilitating neuroplasticity by multimodal stimulation, like virtual reality, or by active assistance in task specific training, like rehabilitation robots associated or not with functional electrical stimulation (FES). The aim of this article is, on one hand, to analize the way in which the existing robots face the biomechanical chalenges of modeling the upper limb's movements and, on the other hand, to evaluate the efficiency of robotics in rehabilitation, by pointing out the results of the existing clinical trials. Finally, possible directions for future research are discussed.

Keywords: visual disturbances, amacrine cells, dopamine deficit, Optical Coherence Tomography

Full text | PDF



SEARCH

STANDARDS

  • Instructions for AUTHORS
  • Peer-review protocol

Submit article

Submit your article to the journal by using the form here:

Submit

Subscriptions

To receive the Ro Journal of NEUROLOGY click here:

SUBSCRIBE
Publicare
Abonare

Partners

Partners' logo

plic-mailredactia@amaltea.ro

Subscribe to the Newsletter

Articles from the journal are licensed under a 
Creative Commons Attribution 4.0 International License

 Terms & Conditions

Open Access Statement

Publisher : AMALTEA Medical Publishing House

Audiența vizată de conținutul acestui site este reprezentată de profesioniștii aparținând comunității medicale și farmaceutice din România și internaționale. Acest site este GDPR-friendly. Prin accesarea acestuia sunteți de acord cu termenele și condițiile. [ click ]     De acord
Contact

trimitere ARTICOLE
email: redactia@amaltea.ro  |  tel.: 0742.155.512, L-V 9.00-18.00

credite & ABONAMENTE
email: info@amaltea.ro |  tel.: 0742.155.511, L-V 9.00-18.00